| Clinical applications of immunohistochemistry in gynecological malignancies. | |
| | |
MedLine Citation:
|
PMID: 17362308 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Over the past two decades, immunohistochemical techniques have improved to such a degree that it is now a common adjuvant test to the traditional hematoxylin and eosin-stained histologic sections. It is used in most realms of surgical pathology and can often aid in final diagnosis and, in some cases, prognosis. However, immunohistochemistry (IHC) is not always helpful and many pitfalls to its use exist. Understanding the basics of IHC, its utility and difficulties will aid clinicians in better understanding how diagnoses are rendered. This study reviews the general principles of IHC and demonstrates its utility with several commonly encountered problematic areas in gynecological pathology. |
| | |
Authors:
|
J Shutter; K A Atkins; K Ghartey; T J Herzog |
Related Documents
:
|
1099568 - Recognizing the allergic individual. 1858608 - Office dermatologic testing: the scabies preparation. 8335058 - Treatment of post-traumatic priapism by means of autologous clot embolization. a case r... 3758008 - Barium swallow as an aid to the diagnosis of grass sickness. 11299528 - Hiv/aids-related electronic queries and responses: a three-year analysis. 10621768 - Suicide in prisons. reflection of the communities served, or exacerbated risk? |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Volume: 17 ISSN: 1048-891X ISO Abbreviation: Int. J. Gynecol. Cancer Publication Date: 2007 Mar-Apr |
Date Detail:
|
Created Date: 2007-03-16 Completed Date: 2007-05-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9111626 Medline TA: Int J Gynecol Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 311-5 Citation Subset: IM |
Affiliation:
|
George Washington University, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma
/
diagnosis*,
pathology*,
secondary Cost-Benefit Analysis Cyclin-Dependent Kinase Inhibitor p16 / analysis Female Genital Neoplasms, Female / diagnosis*, pathology*, secondary Humans Immunohistochemistry / economics, methods* Keratin-20 / analysis Keratin-7 / analysis Neoplasms, Unknown Primary / diagnosis |
| Chemical | |
Reg. No./Substance:
|
0/Cyclin-Dependent Kinase Inhibitor p16; 0/Keratin-20; 0/Keratin-7 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Development of complementary expression patterns of E- and N-cadherin in the mouse liver.
Next Document: Current management of ovarian carcinosarcoma.